Genetics/Genomics News

NEW ORLEANS — Genetic and other evidence indicate that elevated apolipoprotein C-III is a risk factor for CAD, and lowering it may reduce risk for CV events, according to a keynote lecture at the National Lipid Association Scientific Sessions.  

NEW ORLEANS — Genetic research can confirm which risk factors cause CHD and which are merely associated with CHD, according to a speaker at the National Lipid Association Scientific Sessions.

Based on studies in humans and animals, researchers have discovered a new gene linked to stroke related to cerebral small vessel disease.

Shorter telomere length confers greater risk for MI, researchers reported in the Journal of the American College of Cardiology.

Mitral valve prolapse is known to be one of the most common cardiac abnormalities in the general population.

CHICAGO — Although genetic mutations associated with familial hypercholesterolemia are rarer than previously thought, people with these mutations are at high risk for developing early-onset CAD, according to a new study presented at the American College of Cardiology Scientific Session.

A gene transfer therapy improved left ventricular function in patients with HF with reduced ejection fraction, according to the results of a phase 2 clinical trial.

A genetic risk score of 47 known CAD risk single nucleotide polymorphisms may predict recurrent ACS, according to data published in Circulation: Cardiovascular Genetics.

In a study published in Science, an international team of scientists, including researchers from the Perelman School of Medicine at the University of Pennsylvania, suggest that a genetic mutation that raises HDL may increase risk for CHD.

According to the Dutch Lipid Clinic criteria, one in 250 Americans are affected by familial hypercholesterolemia, researchers reported in Circulation.